BOOK
Evidence-based Clinical Chinese Medicine - Volume 2: Psoriasis Vulgaris
Xue Charlie Changli | Lu Chuanjian | Zhang Claire Shuiqing
(2016)
Additional Information
Book Details
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Contents | xxix | ||
| Purpose of the Monograph | v | ||
| How to Use This Monograph | vii | ||
| Some Definitions | vii | ||
| Data Analysis and Interpretation of Results | vii | ||
| Use of Evidence in Practice | viii | ||
| Limitations | viii | ||
| Disclaimer | xi | ||
| Foreword | xiii | ||
| Related Publications | xvi | ||
| Authors and Contributors | xix | ||
| Members of Advisory Committee and Panel | xxi | ||
| Professor Charlie Changli Xue, PhD | xxiii | ||
| Professor Chuanjian Lu, MD | xxv | ||
| Acknowledgments | xxvii | ||
| List of Figures | xxxv | ||
| List of Tables | xxxvii | ||
| 1. Introduction to Psoriasis Vulgaris | 1 | ||
| Risk Factors | 4 | ||
| Pathological Processes | 4 | ||
| Diagnosis | 5 | ||
| Symptom Assessment | 5 | ||
| Evaluation of Psoriasis Symptom Severity | 5 | ||
| Differential Diagnosis | 6 | ||
| Management | 6 | ||
| Treatment Goals | 8 | ||
| References | 10 | ||
| 2. Psoriasis Vulgaris in Chinese Medicine | 13 | ||
| Aetiology and Pathogenesis | 14 | ||
| Syndromes Differentiation and Treatments | 14 | ||
| Oral CHM Treatment Based on Syndrome Differentiation\r | 15 | ||
| Blood Heat | 15 | ||
| Blood Dryness | 16 | ||
| Blood Stasis | 17 | ||
| Topical Therapies of CHM | 17 | ||
| CHM Ointment | 17 | ||
| CHM Baths | 18 | ||
| Acupuncture Therapies and Other CM Therapies | 18 | ||
| Other Management Strategies | 18 | ||
| References | 19 | ||
| 3. Classical Chinese Medicine Literature | 21 | ||
| Classical Literature Search | 22 | ||
| Terms of the Most Likely Psoriasis Vulgaris Citations | 25 | ||
| Representative Citations | 25 | ||
| Syndromes of Psoriasis Vulgaris in Classical Literature | 26 | ||
| Common Formulae and Herbs | 27 | ||
| Common Acupuncture Points | 29 | ||
| Classical Literature in Perspective | 29 | ||
| References | 30 | ||
| 4. Methods for Evaluating Clinical Evidence | 33 | ||
| Introduction | 33 | ||
| Search Strategy | 34 | ||
| Inclusion Criteria | 35 | ||
| Exclusion Criteria | 36 | ||
| Methodological Quality Assessment | 36 | ||
| Statistical Analyses | 38 | ||
| Assessment Using GRADE | 38 | ||
| Outcome Measures | 41 | ||
| References | 42 | ||
| 5. Chinese Herbal Medicine for Psoriasis Vulgaris | 45 | ||
| Previous Systematic Reviews | 45 | ||
| Clinical Evidence: Characteristics | 47 | ||
| Oral Chinese Herbal Medicine | 47 | ||
| Topical Chinese Herbal Medicine | 50 | ||
| Randomised Controlled Trials of Oral CHM | 50 | ||
| Risk of Bias Assessment | 50 | ||
| Effects of Oral CHM | 52 | ||
| PASI 60 | 52 | ||
| Lesion Reduction of 60% | 55 | ||
| Health-related Quality of Life: DLQI | 55 | ||
| Assessment Using GRADE | 57 | ||
| Frequently Reported Herbs in Meta-Analyses Showing Favourable Effect | 57 | ||
| Safety of Oral CHM in Randomised Controlled Trials | 61 | ||
| Controlled Clinical Trials (Non-Randomised) of Oral CHM | 62 | ||
| Non-Controlled Studies of Oral CHM | 63 | ||
| Randomised Controlled Trials of Topical CHM | 63 | ||
| Risk of Bias Assessment | 63 | ||
| Effects of Topical CHM | 64 | ||
| PASI 60 | 64 | ||
| Lesion Reduction of 60% | 66 | ||
| Assessment Using GRADE | 66 | ||
| Frequently Reported Herbs in Meta-Analyses Showing Favourable Effect | 68 | ||
| Safety of Topical CHM in Randomised Controlled Trials | 68 | ||
| Controlled Clinical Trials (Non-Randomised) of Topical CHM | 69 | ||
| Non-Controlled Studies of Topical CHM | 70 | ||
| Summary of Chinese Herbal Medicine Clinical Evidence | 70 | ||
| References | 71 | ||
| 6. Pharmacological Actions of the Common Herbs | 73 | ||
| Experimental Studies of sheng di huang | 73 | ||
| Experimental Studies of dang gui | 74 | ||
| Experimental Studies of chi shao | 74 | ||
| Experimental Studies of dan shen | 75 | ||
| Experimental Studies of tu fu ling | 76 | ||
| Experimental Studies of mu dan pi | 76 | ||
| Experimental Studies of bai xian pi | 77 | ||
| Experimental Studies of zi cao | 78 | ||
| Experimental Studies of gan cao | 79 | ||
| Experimental Studies of ku shen | 80 | ||
| Experimental Studies of di fu zi | 81 | ||
| Summary of Pharmacological Actions of the Common Herbs | 82 | ||
| References | 82 | ||
| 7. Clinical Evidence for Acupuncture and Related Therapies | 89 | ||
| Previous Systematic Reviews | 90 | ||
| Identification of Clinical Studies | 90 | ||
| Randomised Controlled Trials of Acupuncture and Related Therapies\r | 92 | ||
| Risk of Bias Assessment | 92 | ||
| Effects of Acupuncture | 92 | ||
| Effects of Acupuncture plus Moxibustion | 92 | ||
| Controlled Clinical Trials (Non-Randomised) of Acupuncture and Related Therapies\r | 93 | ||
| Non-Controlled Studies of Acupuncture and Related Therapies\r | 93 | ||
| Summary of Acupuncture Clinical Evidence | 93 | ||
| 8. Clinical Evidence for Chinese Medicine Combination Therapy\r | 95 | ||
| Chinese Medicine Combination Therapy for Psoriasis Vulgaris\r | 95 | ||
| Summary of Main Findings | 96 | ||
| 9. Summary and Conclusion | 97 | ||
| Chinese Herbal Medicine | 98 | ||
| Summary of CHM across Evidence Types | 99 | ||
| Acupuncture and Related Therapies | 99 | ||
| Summary of Acupuncture and Related Therapies across Evidence Types\r | 102 | ||
| Implications for Practice | 102 | ||
| Implications for Research | 104 | ||
| Methods | 105 | ||
| Intervention | 105 | ||
| Reporting | 105 | ||
| References | 106 | ||
| Appendix 1: All Included Clinical Studies | 107 | ||
| Glossary | 127 | ||
| Index | 141 |